Draxxin Kp Patent Expiration

Exclusivity Information

Draxxin Kp holds 1 exclusivity out of which 1 has expired. Details of Draxxin Kp's exclusivity codes and their expiration dates are given below.

Drug Exclusivity Drug Exclusivity Expiration
NCI Jun 01, 2024

About Draxxin Kp

Draxxin Kp is a drug owned by ZOETIS INC. Draxxin Kp uses Ketoprofen, Tulathromycin as the active ingredients.

Active Ingredient:

Draxxin Kp uses Ketoprofen, Tulathromycin as the active ingredients. Check out other Drugs and Companies using Ketoprofen, Tulathromycin ingredient.